Collaborative Study to Establish National Reference Standards for Anti-HIV-1 Antibody
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: National reference standards for anti-HIV-1 antibody are needed to evaluate the performance and maintain the quality control of anti-HIV-1 antibody assays. The aim of this study was to prepare a mixed-titer performance panel and assess its suitability as a national reference standard for anti-HIV-1 antibody according to stability, collaboration, and other studies. Methods: Nineteen serum samples from different HIV patients were obtained, along with 15 units of fresh frozen plasma samples with negative anti-HIV-1 antibody results. Ten anti- HIV-1 antibody-positive candidate standards and two negative candidate standards were prepared based on the reactivity in the Alinity i HIV Ag/Ab combo assay (Abbott Laboratories, Wiesbaden, Germany). A collaborative study was conducted across eight laboratories using five anti-HIV-1 antibody assays. Real-time and accelerated stability were evaluated to assess the long-term stability. Results: In the collaborative study, results of all five anti-HIV-1 antibody assays were positive for all 10 candidate standards prepared using HIV patient samples. The CV of each assay for every candidate standard was within 10%, except for one assay result. No real-time and accelerated stability change trend was observed at −70°C or −20°C, supporting that the reference standards were maintained in a stable state at −70°C for long-term storage. Conclusions: The overall results suggest that the 12 candidate standards could serve as national reference standards for anti-HIV-1 antibody.
Abstract
Background: National reference standards for anti-HIV-1 antibody are needed to evaluate the performance and maintain the quality control of anti-HIV-1 antibody assays. The aim of this study was to prepare a mixed-titer performance panel and assess its suitability as a national reference standard for anti-HIV-1 antibody according to stability, collaboration, and other studies. Methods: Nineteen serum samples from different HIV patients were obtained, along with 15 units of fresh frozen plasma samples with negative anti-HIV-1 antibody results. Ten anti- HIV-1 antibody-positive candidate standards and two negative candidate standards were prepared based on the reactivity in the Alinity i HIV Ag/Ab combo assay (Abbott Laboratories, Wiesbaden, Germany). A collaborative study was conducted across eight laboratories using five anti-HIV-1 antibody assays. Real-time and accelerated stability were evaluated to assess the long-term stability. Results: In the collaborative study, results of all five anti-HIV-1 antibody assays were positive for all 10 candidate standards prepared using HIV patient samples. The CV of each assay for every candidate standard was within 10%, except for one assay result. No real-time and accelerated stability change trend was observed at −70°C or −20°C, supporting that the reference standards were maintained in a stable state at −70°C for long-term storage. Conclusions: The overall results suggest that the 12 candidate standards could serve as national reference standards for anti-HIV-1 antibody.
참고문헌 (15)
- "Latest HIV estimates and updates on HIV policies uptake 2021" (2022)[URL]
- "Annual report on the notified HIV/AIDS in Korea 2020" (2022)[URL]
- "Annual report on external quality assessment 2021" (2022)[URL]
- "List of Ministry of Food and Drug Safety Reference Standards" (2022)[URL]
- "ISO Guide 35:2017. Reference materials—Guidance for characterization and assessment of homogeneity and stability. Switzerland: International Organization for Standardization, 2017" (2022)[URL]
- "Recommendations for the preparation, characterization and establishment of international and other biological reference standards (revised 2004). Technical Report Series; No. 932, Annex 2" (2022)[URL]
- Castro AR, "Defibrination of blood plasma for use in serological tests for syphilis", Clin Diagn Lab Immunol, 9, pp.1376~1378 (2002)
- CLSI, "Evaluation of stability of in vitro diagnostic reagents; approved guideline. CLSI EP25-A", Clinical and Laboratory Standards Institute, ~ (2009)
- "Guidebook on Ministry of Food and Drug Safety reference standards, 2022" (2022)[URL]
- Stone M, "Comparison of detection limits of fourth-and fifth-generation combination HIV antigen-antibody, p24 antigen, and viral load assays on diverse HIV isolates", J Clin Microbiol, 56, pp.e02045-17~ (2018)
- Park Younhee, "Performance Evaluation of the Aptima Assays in Comparison with the cobas 6800 Assays for the Detection of HIV-1, HBV, and HCV in Clinical Samples", Annals of Laboratory Medicine, 42(4), pp.447~456 (2022), 대한진단검사의학회[DOI]
- Yang YC, "A collaborative study to establish the first National Standard for HIV-1 RNA nucleic acid amplification techniques(NAT)in Taiwan", J Virol Methods, 191, pp.122~127 (2013)
- "Collaborative study to evaluate the proposed WHO 4th international standard for hepatitis B virus (HBV) DNA for nucleic acid amplification technique (NAT) based assays" (2022)[URL]
- "WHO/BS.2020.2403. Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody" (2022)[URL]
- 박태준, "Stability Evaluation of National Reference Standards for Blood Products in Korea", 한국독성학회지, 33(3), pp.225~231 (2017), 한국독성학회